These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 35498504)
1. Identification of benzothiazones containing a hexahydropyrrolo[3,4- Ma X; Han B; Wang A; Yang L; Huang M; Chowdhury K; Gu J; Zhang K; Lv K RSC Adv; 2020 Apr; 10(24):14410-14414. PubMed ID: 35498504 [TBL] [Abstract][Full Text] [Related]
2. Identification of a new series of benzothiazinone derivatives with excellent antitubercular activity and improved pharmacokinetic profiles. Xiong L; Gao C; Shi YJ; Tao X; Rong J; Liu KL; Peng CT; Wang NY; Lei Q; Zhang YW; Yu LT; Wei YQ RSC Adv; 2018 Mar; 8(20):11163-11176. PubMed ID: 35541526 [TBL] [Abstract][Full Text] [Related]
3. Spirocyclic and Bicyclic 8-Nitrobenzothiazinones for Tuberculosis with Improved Physicochemical and Pharmacokinetic Properties. Zhang G; Howe M; Aldrich CC ACS Med Chem Lett; 2019 Mar; 10(3):348-351. PubMed ID: 30891138 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of triazole congeners of nitro-benzothiazinones potentially active against drug resistant Sahoo SK; Ahmad MN; Kaul G; Nanduri S; Dasgupta A; Chopra S; Yaddanapudi VM RSC Med Chem; 2022 May; 13(5):585-593. PubMed ID: 35694687 [TBL] [Abstract][Full Text] [Related]
5. Identification of benzothiazinones containing an oxime functional moiety as new anti-tuberculosis agents. Wang A; Lv K; Tao Z; Gu J; Fu L; Liu M; Wan B; Franzblau SG; Ma C; Ma X; Han B; Wang A; Xu S; Lu Y Eur J Med Chem; 2019 Nov; 181():111595. PubMed ID: 31408806 [TBL] [Abstract][Full Text] [Related]
6. Identification of Better Pharmacokinetic Benzothiazinone Derivatives as New Antitubercular Agents. Lv K; You X; Wang B; Wei Z; Chai Y; Wang B; Wang A; Huang G; Liu M; Lu Y ACS Med Chem Lett; 2017 Jun; 8(6):636-641. PubMed ID: 28626525 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and Antitubercular Activity of New Benzo[b]thiophenes. Mahajan PS; Nikam MD; Nawale LU; Khedkar VM; Sarkar D; Gill CH ACS Med Chem Lett; 2016 Aug; 7(8):751-6. PubMed ID: 27563398 [TBL] [Abstract][Full Text] [Related]
8. 1H-1,2,3-Triazole tethered isatin-moxifloxacin: Design, synthesis and in vitro anti-mycobacterial evaluation. Jiang Y; Qian A; Li Y Arch Pharm (Weinheim); 2019 Jul; 352(7):e1900040. PubMed ID: 31106443 [TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of 11α-substituted bile acid derivatives as potential anti-tuberculosis agents. Pore VS; Divse JM; Charolkar CR; Nawale LU; Khedkar VM; Sarkar D Bioorg Med Chem Lett; 2015 Oct; 25(19):4185-90. PubMed ID: 26299346 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of nitrofuranyl methyl N-heterocycles derivatives as novel antitubercular agents. Wang A; Li W; Wang B; Lv K; Wang H; Liu M; Guo H; Lu Y Future Med Chem; 2018 Sep; 10(17):2059-2068. PubMed ID: 29992836 [TBL] [Abstract][Full Text] [Related]
13. Identification of benzothiazinones containing 2-benzyl-2,7-diazaspiro[3.5]nonane moieties as new antitubercular agents. Wang A; Ma C; Chai Y; Liu X; Lv K; Fu L; Wang B; Jia X; Liu M; Lu Y Eur J Med Chem; 2020 Aug; 200():112409. PubMed ID: 32460114 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis. Wang A; Xu S; Chai Y; Xia G; Wang B; Lv K; Ma C; Wang D; Wang A; Qin X; Liu M; Lu Y Eur J Med Chem; 2021 Jun; 218():113398. PubMed ID: 33823392 [TBL] [Abstract][Full Text] [Related]
15. Novel Benzylidenehydrazide-1,2,3-Triazole Conjugates as Antitubercular Agents: Synthesis and Molecular Docking. Shaikh MH; Subhedar DD; Nawale L; Sarkar D; Khan FAK; Sangshetti JN; Shingate BB Mini Rev Med Chem; 2019; 19(14):1178-1194. PubMed ID: 30019644 [TBL] [Abstract][Full Text] [Related]
16. The 8-Pyrrole-Benzothiazinones Are Noncovalent Inhibitors of DprE1 from Mycobacterium tuberculosis. Makarov V; Neres J; Hartkoorn RC; Ryabova OB; Kazakova E; Šarkan M; Huszár S; Piton J; Kolly GS; Vocat A; Conroy TM; Mikušová K; Cole ST Antimicrob Agents Chemother; 2015 Aug; 59(8):4446-52. PubMed ID: 25987616 [TBL] [Abstract][Full Text] [Related]
17. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents. Lokesh BVS; Prasad YR; Shaik AB Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506 [TBL] [Abstract][Full Text] [Related]
18. Gatifloxacin-1,2,3-triazole-isatin hybrids and their antimycobacterial activities. Ding Z; Hou P; Liu B Arch Pharm (Weinheim); 2019 Oct; 352(10):e1900135. PubMed ID: 31441087 [TBL] [Abstract][Full Text] [Related]